7.36 USD
-1.26
14.62%
At close Apr 30, 4:00 PM EDT
After hours
7.50
+0.14
1.90%
1 day
-14.62%
5 days
26.24%
1 month
35.29%
3 months
28.22%
6 months
77.35%
Year to date
40.73%
1 year
-38.31%
5 years
-6.24%
10 years
-6.24%
 

About: LifeMD Inc is a direct-to-patient telehealth company that provides a smarter, cost-effective, and more convenient way of accessing comprehensive, virtual healthcare. Its telehealth platform seamlessly integrates a clinician-centric electronic medical record (EMR) system, proprietary algorithms for case-load balancing and scheduling, customer relationship management functionality, remote and in-home lab testing, and digital prescription capabilities, patient-provider audio/video interfacing, cloud pharmacy fulfillment, and more. In addition to telehealth offerings, the company sells nutritional supplements and other over-the-counter products. The company has two operating segments: Telehealth and WorkSimpli. The company generates the majority of its revenue from the Telehealth segment.

Employees: 336

0
Funds holding %
of 7,425 funds
Analysts bullish %

Fund manager confidence

Based on 2024 Q4 regulatory disclosures by fund managers ($100M+ AUM)

63% more call options, than puts

Call options by funds: $775K | Put options by funds: $476K

50% more repeat investments, than reductions

Existing positions increased: 39 | Existing positions reduced: 26

47% more first-time investments, than exits

New positions opened: 22 | Existing positions closed: 15

6% more funds holding

Funds holding: 100 [Q3] → 106 (+6) [Q4]

2.77% less ownership

Funds ownership: 39.82% [Q3] → 37.05% (-2.77%) [Q4]

12% less capital invested

Capital invested by funds: $89.9M [Q3] → $79.4M (-$10.5M) [Q4]

Research analyst outlook

2 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
$14
90%
upside
Avg. target
$14.50
97%
upside
High target
$15
104%
upside

2 analyst ratings

positive
100%
neutral
0%
negative
0%
HC Wainwright & Co.
Yi Chen
33% 1-year accuracy
57 / 173 met price target
90%upside
$14
Buy
Reiterated
30 Apr 2025
Cantor Fitzgerald
Sarah James
28% 1-year accuracy
28 / 99 met price target
104%upside
$15
Overweight
Reiterated
11 Mar 2025

Financial journalist opinion

Based on 8 articles about LFMD published over the past 30 days

Positive
The Motley Fool
1 day ago
Why Hims & Hers Health and LifeMD Are Skyrocketing Today
Shares of Hims & Hers Health (HIMS 25.46%) and LifeMD (LFMD 35.41%) are surging on Tuesday. The companie' stocks had jumped 24% and 34%, respectively, as of 3:15 p.m.
Why Hims & Hers Health and LifeMD Are Skyrocketing Today
Neutral
GlobeNewsWire
1 day ago
LifeMD Announces Plans to Expand Affordable Access to Wegovy® for Cash-Pay Patients
NEW YORK, April 29, 2025 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, announced plans to offer broad, affordable, and streamlined access to Wegovy® (semaglutide) through NovoCare® Pharmacy. This integration offers a simplified pathway for cash-pay patients to access all FDA-approved dose strengths of Wegovy® directly within LifeMD's virtual care platform.
LifeMD Announces Plans to Expand Affordable Access to Wegovy® for Cash-Pay Patients
Neutral
GlobeNewsWire
2 days ago
LifeMD to Report First Quarter 2025 Financial Results on May 6
NEW YORK, April 28, 2025 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, announces that it will report financial results for the three months ended March 31, 2025 after the close of the U.S. financial markets on May 6, 2025 and will host a conference call beginning at 4:30 p.m. Eastern time.
LifeMD to Report First Quarter 2025 Financial Results on May 6
Neutral
Business Wire
2 days ago
Medifast Announces First Quarter 2025 Financial Results
BALTIMORE--(BUSINESS WIRE)--Medifast (NYSE: MED), the health and wellness company known for its habit-based and coach-guided lifestyle solution, OPTAVIA®, today reported results for the first quarter ended March 31, 2025. First Quarter 2025 Revenue of $115.7 million, with revenue per active earning coach of $4,556 Independent active earning OPTAVIA coaches of 25,400 Net loss of $0.8 million, which includes an unrealized gain on investment in LifeMD (Nasdaq: LFMD) common stock of $0.4 million (n.
Medifast Announces First Quarter 2025 Financial Results
Neutral
GlobeNewsWire
2 days ago
LifeMD Acquires Women's Health Provider Optimal Human Health MD to Accelerate Entry into the Women's Health Market
NEW YORK, April 28, 2025 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, today announced the acquisition of key assets from Optimal Human Health MD (“Optimal”), a nationwide women's health virtual care provider. This strategic acquisition marks LifeMD's official entry into the women's health market and establishes a scalable clinical foundation for a comprehensive virtual health program under the LifeMD brand, focused on hormone health, bone density, metabolism, and long-term wellness.
LifeMD Acquires Women's Health Provider Optimal Human Health MD to Accelerate Entry into the Women's Health Market
Neutral
GlobeNewsWire
1 week ago
LifeMD Expands Insurance Acceptance to Medicare Beneficiaries for Qualifying Virtual Primary Care, Including in its Weight Loss Programs
NEW YORK, April 17, 2025 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, today announced expanded acceptance of insurance to Medicare beneficiaries for qualifying care. Initially available to more than 21 million Medicare Part B beneficiaries in 26 states, the company expects to expand access to medically necessary services for more than 60 million Medicare beneficiaries nationwide, with access to qualifying services across 49 states anticipated by the end of the second quarter.
LifeMD Expands Insurance Acceptance to Medicare Beneficiaries for Qualifying Virtual Primary Care, Including in its Weight Loss Programs
Positive
Seeking Alpha
3 weeks ago
LifeMD Is Back To Life
LifeMD's weight management segment is regaining competitiveness due to the end of GLP-1 compound shortages and expanded insurance coverage, including Medicare. The company is seeing significant growth in its virtual care platform, with Q4 revenues up 43% and core telehealth revenues up 60%. LifeMD is expanding its insurance coverage, aiming to cover 150M lives by 2025, and launching new products in behavioral and women's health.
LifeMD Is Back To Life
Neutral
GlobeNewsWire
1 month ago
LifeMD to Participate in the 24th Annual Needham Virtual Healthcare Conference
NEW YORK, March 31, 2025 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, announces that management will be participating in the 24th Annual Needham Virtual Healthcare Conference taking place April 7-10, 2025. Management will be presenting a corporate overview and will be holding one-on-one meetings with investors.
LifeMD to Participate in the 24th Annual Needham Virtual Healthcare Conference
Neutral
GlobeNewsWire
1 month ago
LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock
NEW YORK, March 25, 2025 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, today announced that its Board of Directors has authorized a cash dividend to holders of the Company's 8.875% Series A Cumulative Perpetual Preferred Stock (Nasdaq: LFMDP) equal to $0.5546875 per share. The preferred dividend will be paid on April 15, 2025, to holders of record at the close of business on April 4, 2025.
LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock
Neutral
Seeking Alpha
1 month ago
LifeMD, Inc. (LFMD) Q4 2024 Earnings Call Transcript
LifeMD, Inc. (NASDAQ:LFMD ) Q4 2024 Results Conference Call March 10, 2025 4:30 PM ET Company Participants Justin Schreiber - Chairman and Chief Executive Officer Marc Benathen - Chief Financial Officer Conference Call Participants David Larsen - BTIG Steve Dechert - KeyBanc Brooks O'Neil - Lake Street Capital Markets Steven Valiquette - Mizuho Securities Alex Fuhrman - Craig-Hallum Capital Group Sarah James - Cantor Anderson Schock - B. Riley Securities Operator Good afternoon.
LifeMD, Inc. (LFMD) Q4 2024 Earnings Call Transcript
Charts implemented using Lightweight Charts™